A lower cost alternative to an oral medication used to treat multiple sclerosis has launched in the U.S. market by a Mahwah-based firm. https://trib.al/gNr5tXi
A lower cost alternative to an oral medication used to treat multiple sclerosis has launched in the U.S. market by a Mahwah-based firm. https://trib.al/gNr5tXi